AGM
INFI

Alpine Global Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Alpine Global Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24,575
Closed -$52K – 382
2020
Q4 		$52K Buy
+24,575
New +$40.5K 0.01% 192

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Alpine Global Management's INFI Position: Q1 2021 in Review

Alpine Global Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2021, closing a stake of 24,575 shares — an estimated $52K sold.

Alpine Global Management first reported a position in INFI in Q4 2020 and held it in 1 quarter. The position peaked at $52K in Q4 2020. 83 funds tracked by Wall St. Rank hold INFI as of Q1 2021.

  • Alpine Global Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Alpine Global Management sold 24,575 Infinity Pharmaceuticals, Inc. shares in Q1 2021, an estimated $52K.
  • Alpine Global Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2020 and held it in 1 quarter.
  • Alpine Global Management's Infinity Pharmaceuticals, Inc. position peaked at $52K in Q4 2020.
  • 83 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2021.

Based on Alpine Global Management's 13F filing for Q1 2021, filed 13 May 2021.